Abstract

EPH129 Hospitalizations for Chemotherapy-Induced Febrile Neutropenia in Patients With Lung Cancer in France From 2017 to 2020

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Chemotherapy-induced neutropenia and emerging agents for prevention and treatment: A review
Douglas W Blayney ... Lee Schwartzberg
Evidence-based Oncology | VOL. 109
Douglas W Blayney, et. al.Douglas W Blayney ... Lee Schwartzberg
21 Jun 2022
Adjuvant treatment patterns and outcomes in patients with stage IB-IIIA non-small cell lung cancer in France, Germany, and the United Kingdom based on the LuCaBIS burden of illness study
Christos Chouaid ... Ilias Kontoudis
Lung cancer (Amsterdam, Netherlands) | VOL. 124
Christos Chouaid, et. al.Christos Chouaid ... Ilias Kontoudis
10 Aug 2018
Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study).
Christos Chouaïd ... Jérôme Fernandes
PloS one | VOL. 12
Christos Chouaïd, et. al.Christos Chouaïd ... Jérôme Fernandes
25 Aug 2017
OA16.05 Socioeconomic Determinants of Late Diagnosis of Lung Cancer in France: A Nationwide Study (the TERRITOIRE Study)
Pierre Jean Souquet ... Pierre Chauvin
Journal of Thoracic Oncology | VOL. 12
Pierre Jean Souquet, et. al.Pierre Jean Souquet ... Pierre Chauvin
01 Jan 2017
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set
-
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
--
21 Jun 2024
Market entry agreements for innovative pharmaceuticals subject to indication broadening: a case study for pembrolizumab in the Netherlands.
Renaud J S D Heine ... Carin A Uyl-De Groot
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Renaud J S D Heine, et. al.Renaud J S D Heine ... Carin A Uyl-De Groot
21 Jun 2024
MSR99 A Stacked Ensemble Approach for Building Composite Measure Models in Healthcare
P Shi ... S Zhang
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 27
P Shi, et. al.P Shi ... S Zhang
15 Jun 2024
EE98 A Theory-Based Framework to Incorporate Health Equity in Economic Assessments
S Subramanian ... S Hoover
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 27
S Subramanian, et. al.S Subramanian ... S Hoover
15 Jun 2024
View more papers